BIOGEN - CHARGE TO IMPACT Q4 NET INCOME BY $1.26 PER SHARE - SEC FILING
BIOGEN - EXPECTS $222 MILLION EXPENSE FOR Q4 2025 - SEC FILING
Source text: [ID:n0000875045-26-000003]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.